A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Novartis
Allist Pharmaceuticals, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Erasca, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.